Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here ...

Shares of Stryker Corp. SYK rose 1.00% to $359.39 Wednesday, on what proved to be an all-around rough trading session for the ...

Zimmer Biomet (ZBH) shares reached a session low on Tuesday as the company issued cautious remarks on its outlook during its ...

The growth of the neurovascular devices market is largely fueled by the increasing burden of neurovascular disorders, rapid technological advancements in devices, a growing preference for minimally ...

Stryker, a medical technology company developing implants and surgical equipment, and other defendants were slapped with an employment lawsuit on Sept. 9 in California Superior Court for Los Angeles ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced that it has been awarded a contract ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Stryker (SYK – Research Report) and 10x Genomics (TXG – Research Report). Claim 70% Off TipRa ...

In a report released today, Lee Hambright from Bernstein maintained a Buy rating on Stryker, with a price target of $465.00.

Inari Medical Inc. was just a 25-person startup when Drew Hykes arrived in 2017 as chief commercial officer.What most ...

The global laparoscopic instrument market reached USD 10.8 billion in 2020 and is forecasted to reach USD 22.6 billion by 2027, with a CAGR of 11.7% during 2021-2027. Factors such as the shift towards ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...